aspirin--butalbital-and-caffeine-drug-combination and Migraine-Disorders

aspirin--butalbital-and-caffeine-drug-combination has been researched along with Migraine-Disorders* in 3 studies

Trials

1 trial(s) available for aspirin--butalbital-and-caffeine-drug-combination and Migraine-Disorders

ArticleYear
Eletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: results from a multiple-attack study.
    Cephalalgia : an international journal of headache, 2005, Volume: 25, Issue:9

    The aim of this study was to examine efficacy and tolerability of eletriptan in patients switched from barbiturate-containing combinations (Fiorinal), Fioricet. Migraineurs (n = 160) meeting IHS criteria, with unsatisfactory response in the past year to butalbital-containing combinations, treated up to 16 attacks over 3 months with eletriptan 40 mg. Assessments included headache response and pain-free rates and functional impairment at baseline and 2 h postdose, and global ratings of treatment satisfaction at 24 h. At 2 h postdose, average headache response and pain-free rates were 71% (95% CI, 69-74%) and 37% (95% CI, 35-40%), respectively; 68.5% of patients (95% CI, 65-72%) reported functional response. Within-patient analysis found no efficacy diminution over time (no tolerance). Average headache recurrence rate was 20% (95% CI, 18-23%). Eletriptan was well-tolerated; 6 (3.7%) patients discontinued due to adverse events. There were no serious treatment-related adverse events. We conclude that in poor responders to butalbital-caffeine combinations, switching to eletriptan 40 mg was well-tolerated and efficacious.

    Topics: Acetaminophen; Adolescent; Adult; Analgesics; Aspirin; Barbiturates; Caffeine; Drug Combinations; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Pyrrolidines; Quality of Life; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines

2005

Other Studies

2 other study(ies) available for aspirin--butalbital-and-caffeine-drug-combination and Migraine-Disorders

ArticleYear
Organic dissociative syndrome associated with antimigraine pharmacotherapy.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1991, Volume: 36, Issue:8

    This report describes an acute organic brain syndrome with a fugue-like state in association with antimigraine pharmacotherapy. The differential diagnosis of: 1. possible psychotoxic effects of the combination of propranolol, imipramine, and butalbital; 2. confusional migraine with amnesia; and 3. psychogenic dissociation is considered. Although organically induced dissociative states are of clinical, neuropsychological and medico-legal significance, the DSM-III and DSM-III-R have specific categories only for dissociative conditions that are strictly psychogenic in origin.

    Topics: Adolescent; Analgesics; Aspirin; Barbiturates; Caffeine; Dissociative Disorders; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipramine; Migraine Disorders; Phenacetin; Substance-Related Disorders

1991
Headache--diagnosis and effective management.
    The Western journal of medicine, 1984, Volume: 140, Issue:6

    Topics: Analgesics; Aspirin; Barbiturates; Caffeine; Cluster Headache; Drug Combinations; Ergotamine; Headache; Humans; Methylamines; Migraine Disorders; Parasympatholytics; Phenacetin; Temporomandibular Joint Dysfunction Syndrome

1984